相关实验视频

Updated: Aug 10, 2026

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

血小板激活因子乙基氨酸酶可以防止心肌缺血-再输血损伤

E N Morgan1, E M Boyle, W Yun

  • 1Department of Surgery, University of Washington, Seattle, WA 98195, USA.

Circulation
|November 24, 1999
PubMed
概括

血小板激活因子乙氨酶 (PAF-AH) 在子中显著降低了心肌缺血-再输血损伤. 这种酶抑制了PAF,PAF是一种强大的组织损伤媒介,从而改善了心脏功能,减少了亡.

更多相关视频

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury11:17

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

相关概念视频

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.